Abstract:Background Cyclosporine A (CsA) is an effective drug to prevent rejection response after penetrating keratoplasty (PKP).Appropriate dosage forms and right administrating route is very important for improving the bioavailability of CsA.Objective This study was to investigate the preventing effect of CsA microspheres via subconjunctive and anterior chamber injection and CsA eye drops on immune rejection after PKP.Methods Sixty eyes of 60 clean adult New Zealand white rabbits served as receipts,and 60 eyes of 30 clean adult pigmented rabbits were used as the donors.The receipts were randomized into the blank control group (only PKP group),subconjunctival CsA injection group,subconjunctival vector injection group,anterior chamber CsA injection group,anterior chamber vector injection group,and 1％ CsA eye drops group.PKP was performed on the all rabbits,and then the CsA microsphere (0.1 ml,12 g/L) or blank microsphere (0.1 ml) were respectively administered in the corresponding groups.The corneal grafts were examined by slit lamp microscope regularly,and rejection index (RI)was calculated based on the corneal opacity,edema and neovascularization.The intraocular pressure (IOP) of operative eyes was measured by Tono-pen tonometer before operation,3 days,1 week,2 weeks,3 weeks,1 month,2 months and 3 months after operation,respectively.Histopathological examination on corneal grafts was performed 1month and 3 months after operation.Results The IOP of all the rabbits lowed after operation,but there was no statistical difference in different time points and various groups (Ftime =29.210,P =0.000; Fgroup =0.254,P =0.938).The grafts of the blank control group,subconjunctival vector injection group and the anterior chamber vector injection group showed varied degrees of corneal opacity and neovascularization 2-3 weeks after operation,and the degree of graft opacity was aggravated obviously in the fourth week,with the RI 8.60±1.52,8.60±0.55 and 8.80±0.84 individually.Neovascularization of the grafts in the subconjunctival CsA injection group,anterior chamber CsA injection group,and 1％ CsA eye drops group was found 3 weeks after operation,and the RI were 4.40±0.89,3.20±0.84 and 3.00±0.71,showing a significantly lower than that of the control groups (P＜0.05).Mild inflammatory response of the grafts was seen in the anterior chamber CsA injection group,but it was lightened over time.The histopathological examination revealed obvious thickening of corneal grafts,neovascularization and infiltration of lots of inflammatory cells in the blank control group,subconjunctival vector injection group and the anterior chamber vector injection group.However,only slight new blood vessels and inflammatory response were seen on the subconjunctival CsA injection group,anterior chamber CsA injection group,and 1％ CsA eye drops group.Conclusions Administration of CsA in different methods can prevent the immune rejection after PKP in rabbit eyes,the effect of giving drugs via anterior chamber injection is better than that via subconjunctive pathyway.

Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty.

Effects of the FK506 nanoparticles delivery system on a penetrating keratoplasty rejection model in the rat

Studies on the Effects of the Immunosuppressant FK-506 on the High-Risk Corneal Graft Rejection.

Ocular safety and pharmacokinetics study of FK506 suspension eye drops after corneal transplantation.

Clinical evaluation of topical FK506 in the management of therapeutic keratoplasty for fungal keratitis

[The study of FK506 eye drops preventing and treating immune rejection on limbal allograft transplantation]

Comparison between the effect of Tripterygiitotorum (T_Ⅱ) and FK506 ophthalmic solutions on the corneal allograft rejection

Effect of locally administered rapamycin and cyclosporin A on penetrating keratoplasty rejection rat model

Experimental studies of rapamycin eye drops on the prevention of penetrating keratoplasty rejection in a rat model

Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration.

Effect of Switch from Cyclosporine to FK506 on Renal Graft Outcome in Patients after Initial Acute Rejection

The Effects of Immunosuppressant Mycophenolate Mofetil on Penetrating Keratoplasty Rejection Model in Rat

Applications of Immunosuppressant FK506 on Limbal Tran Splantation in Rabbits

Prevention of cyclosporine A in different methods of administrations on the rejection after penetrating keratoplasty in rabbit eyes

Effects of TGF-β1 on Expression of IL-10 in Immunological Rejection after High-Risk Penetrating Keratoplasty

Comparison of immunogenicity and porcine-to-rhesus lamellar corneal xenografts survival between fresh preserved and dehydrated porcine corneas.

Development and Effects of FTY720 Ophthalmic Solution on Corneal Allograft Survival

Effects of Mutant Kringle 5 Eye Drops on the Survival Time of Corneal Allografts in Rat

Systematic Review of Penetrating Keratoplasty Rejection Treated by Immunosuppressants

Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection

Electrospun Polymer Fibers Modified with FK506 for the Long-Term Treatment of Acute Cardiac Allograft Rejection in a Heart Transplantation Model.